Team size: Three

What are the most significant cases or transactions that your legal team has recently been involved in?

The past year has been one of the most demanding and consequential periods for our legal team, with several high-stakes matters running in parallel across Brazil and the United States. In Brazil, our work has spanned regulatory proceedings before ANS and ANVISA, competition law matters before CADE, and long-running litigation at the highest judicial levels, including a significant favorable ruling at the TST after nearly two decades of proceedings. Across these workstreams, a recurring theme has been the need to coordinate rapidly across multiple regulatory bodies, outside counsel networks, and internal stakeholders simultaneously, often under tight timelines and with significant business consequences.

Beyond Brazil, our team has supported OUS litigation and regulatory matters as part of Lilly’s global legal structure, working across jurisdictions on matters involving product integrity, market access, and regulatory compliance. What distinguishes our approach is the integration of Brazilian market expertise with a global legal perspective, ensuring that local proceedings are managed not in isolation, but in alignment with Lilly’s broader strategic and regulatory posture.

What strategies has your legal team adopted to manage disputes and mitigate risks in Brazil’s dynamic business environment?

Brazil’s legal and regulatory environment demands a proactive, intelligence-driven approach. Reactive legal defense is rarely sufficient when regulatory bodies, competitors, and third parties can move quickly and in coordinated ways. Our strategy rests on three pillars. First, early monitoring: we track regulatory proceedings, competitor conduct, and legislative developments systematically, so that legal risks are identified before they become disputes.

Second, outside counsel integration: our network of Brazilian firms is embedded in our planning processes, not just engaged at the point of escalation. This allows for faster, more calibrated responses.

Third, cross-border alignment: many of the risks we face in Brazil have implications for global regulatory strategy, government pricing, or global supply chain, and vice versa. Managing those connections proactively, rather than treating Brazil as an isolated jurisdiction, has been a significant differentiator for our team.